GATA1 gene silencing inhibits invasion, proliferation and migration of cholangiocarcinoma stem cells via disrupting the PI3K/AKT pathway

• Main Authors: Shi G, Zhang H, Yu Q, Hu C, Ji Y
• Format: Article
• Language: English
• Published: Dove Medical Press 2019-07-01
• Series: OncoTargets and Therapy
• Subjects: GATA1; gene silencing; cholangiocarcinoma stem cells; PI3K/AKT pathway; proliferation; migration; invasion
• Online Access: https://www.dovepress.com/gata1-gene-silencing-inhibits-invasion-proliferation-and-migration-of--peer-reviewed-article-OTT

Guang Shi,1 Hong Zhang,2 Qiong Yu,1 Chunmei Hu,1 Youbo Ji31Department of Hematology and Oncology, the Second Hospital of Jilin University, Changchun 130041, People’s Republic of China; 2Department of Clinical Medicine, Changchun Medical College, Changchun 130031, People’s Republic of China; 3Department of Pain, the Second Hospital of Jilin University, Changchun 130041, People’s Republic of ChinaBackground/aims: Intrahepatic cholangiocarcinoma (CCA) is the second most prevalent type primary liver malignancy, accompanied by an increasing global incidence and mortality rate. Research has documented the contribution of the GATA binding protein-1 (GATA1) in the progression of liver cancer. Here, we aim to investigate the role of GATA1 in CCA stem cells via the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway.Methods: Initially, microarray-based gene expression profiling was employed to identify the differentially expressed genes associated with CCA. Subsequently, an investigation was conducted to explore the potential biological significance behind the silencing of GATA1 and the regulatory mechanism between GATA1 and PI3K/AKT pathway. CCA cell lines QBC-939 and RBE were selected and treated with siRNA against GATA1 or/and a PI3K/AKT pathway inhibitor LY294002. In vivo experiment was also conducted to confirm in vitro findings.Results: GATA1 exhibited higher expression in CCA samples and was predicted to affect the progression of CCA through blockade of the PI3K/AKT pathway. siRNA-mediated downregulation of GATA1 and LY294002 treatment resulted in reduced proliferation, migration and invasion abilities of CCA stem cells, together with impeded tumor growth, and led to increased cell apoptosis and primary cilium expression. Additionally, the siRNA-mediated GATA1 downregulation had an inhibitory effect on the PI3K/AKT pathway. LY294002 was manifested to enhance the inhibitory effects of GATA1 inhibition on CCA progression. These in vitro findings were reproduced in vivo on siRNA against GATA1 or LY294002 injected nude mice.Conclusion: Altogether, the present study highlighted that downregulation of GATA1 via blockade of the PI3K/AKT pathway could inhibit the CCA stem cell proliferation, migration and invasion, and tumor growth, and promote cell apoptosis, primary cilium expression.Keywords: GATA1, gene silencing, cholangiocarcinoma stem cells, PI3K/AKT pathway, proliferation, migration, invasion